Investigation of a dual CD chiral CE system for separation of glitazone compounds

Electrophoresis

Volumn 30, Issue 16, 2009, Pages 2853-2861

  Jamali, Babak ^a   Bjørnsdottir, Inga ^a   Cornett, Claus ^b   Hansen, Steen Honoré ^b  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Balaglitazone; Dual CD; Optimization; Pioglitazone; Rosiglitazone

Indexed keywords

CHIRALITY; DRUG PRODUCTS; PH;

BALAGLITAZONE; CE SYSTEMS; CHIRAL CE; CHIRAL SEPARATIONS; DUAL CD; HIGH RESOLUTION; OPTIMISATIONS; PIOGLITAZONE; ROSIGLITAZONE; Β-CD;

ENANTIOMERS;

BALAGLITAZONE; BETA CYCLODEXTRIN; BUFFER; GLITAZONE DERIVATIVE; HEPTAKIS (6 SULFOBUTYLETHER) BETA CYCLODEXTRIN; HEPTAKIS(2,6 O DIMETHYL) BETA CYCLODEXTRIN; PIOGLITAZONE; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; CAPILLARY ELECTROPHORESIS; CHEMICAL STRUCTURE; CHIRALITY; CIRCULAR DICHROISM; ENANTIOMER; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROCESS OPTIMIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; SEPARATION TECHNIQUE; STRUCTURE ANALYSIS;

EID: 70450219474     PISSN: 01730835     EISSN: 15222683     Source Type: Journal    
DOI: 10.1002/elps.200800812     Document Type: Article

References (22)

1. Ariënes, E. J., Soudijin, W., Timmermans, P. B. M. W. M.(Eds.), Stereochemistry and Biological Activity of Drugs, Blackwell, London 1983.
2. Campbell, D. B., Eur. J. Drug Metab. Pharmacokinet. 1990, 15, 109-125.
3. Fassihi, A. R., Int. J. Pharm. 1993, 92, 1-14.
4. Matthijs, N., Hemelryck, S. V., Maftouh, M., Massart, D. L., Heyden, Y. V., Anal. Chim. Acta 2004, 525, 247-263.
5. Abushoffa, A. M., Fillet, M., Servais, A. C., Hubert, P., Crommen, J., Electrophoresis 2003, 24, 343-350.
6. Abushoffa, A. M., Burjanadze, N., Blaschke, G., Crommen, J., Chankvetadze, B., J. Sep. Sci. 2002, 25, 10-16.
7. Abushoffa, A. M., Fillet, M., Hubert, P., Crommen, J., J. Chromatogr. A 2002, 948, 321-329.
8. Chankvetadze, B., Burjanadze, N., Crommen, J., Blaschke, G., Chromatographia 2001, 53, 296-301.
9. Szücs, R., Caron, I., Taylor, K. A., Gee, S. P., Ferguson, P. D., Kelly, M. A., Beaman, J. V. et al., J. Micro. Sep. 2000, 12, 568-576.
10. Grard, s., Morin, P., Dreux, M., Ribet, J. P., Electrophoresis 2000, 21, 3028-3034.
11. Fillet, M., Hubert, P., Crommen, J., J. Chromatogr. A 2000, 875, 123-134.
12. Fillet, M., Chankvetadze, B., Crommen, J., Blaschke, G., Electrophoresis 1999, 20, 2691-2697.
13. Izumoto, I., Nishi, H., Electrophoresis 1999, 20, 189-197.
14. Fillet, M., Fosting, L., Schomburg, G., Hubert, P., Crommen, J., Biomed. Chrom. 1998, 12, 131-132.
15. Fillet, M., Fosting, L., Crommen, J., J. Chromatogr. A 1998, 817, 113-119.
16. Fillet, M., Hubert, P., Crommen, P., Electrophoresis 1998, 19, 2834-2840.
17. Fillet, M., Bechet, I., Schomburg, G., Hubert, P., Crommen, P., J. High Resol. Chrom. 1996, 19, 669-673.
18. Lurie, I. S., J. Chromatogr. A 1997, 792, 297-307.
19. Terabe, S., Miyashita, Y., Ishihama, Y., Shibata, O., J. Chromatogr. A 1993, 636, 47-55.
20. Jamali, B., Theill, G. C., Sørensen, L. L., J. Chromatogr. A 2004, 1049, 183-187.
21. Jamali, B., Bjørnsdottir, I., Nordfang, O., Hansen, S. H., J. Pharm. Biomed. Anal. 2007, 46, 82-87.
22. Internal report, Novo Nordisk A/S, R&D, Måløv, Denmark.